StonvexLoading…
StonvexCore line items from ASH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q3 2026 (Est.) Expected 2026-07-27 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $490.82M | $868.00M | $386.00M | $1.82B | $1.35B |
Operating Income | Not available | $33.00M | $-6.00M | $-775.00M | $-836.00M |
Net Income | Not available | $4.00M | $-12.00M | $-845.00M | $-877.00M |
EPS (Diluted) | $1.11 | $0.08 | $-0.26 | $-18.23 | $-18.85 |
Total Assets | Not available | $4.50B | $4.52B | $4.61B | $4.62B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $343.00M | $304.00M | $215.00M | $207.00M |
Free Cash Flow OCF − CapEx | Not available | $144.00M | $111.00M | $36.00M | $30.00M |
Shares Outstanding | Not available | 46 | 46 | 46.00M | 47.00M |